Skip to main content
Open this photo in gallery:

Morgan Stanley posted a 150-per-cent jump in its first-quarter profit.Lucas Jackson/Reuters

Morgan Stanley lost nearly US$1-billion from the collapse of family office Archegos Capital Management, the bank said on Friday, muddying its 150-per-cent jump in first-quarter profit that was powered by a boom in trading and deal-making.

Morgan Stanley was one of several banks that had exposure to Archegos, which defaulted on margin calls late last month and triggered a fire sale of stocks across Wall Street.

Morgan Stanley lost US$644-million by selling stocks it held related to Archegos’s positions, and another US$267-million trying to “de-risk” them, Morgan Stanley chief executive James Gorman said on a call with analysts.

“I regard that decision as necessary and money well spent,” he said.

Morgan Stanley is not alone in nursing losses as a prime broker for Archegos. Switzerland’s Credit Suisse Group AG and Japan’s Nomura Holdings Inc. bore the brunt, having lost US$4.7-billion and US$2-billion, respectively.

Goldman Sachs Group Inc. , Deutsche Bank and Wells Fargo & Co. also handled Archegos positions but exited them without losses, Reuters and other media outlets have reported.

The collateral requirements Morgan Stanley imposed on Archegos were based on information that “turned out not to be true,” chief financial officer Jonathan Pruzan said. Morgan Stanley was not aware that Archegos had similar, large positions at several banks across Wall Street.

Nonetheless, Morgan Stanley has not changed its view about the prime brokerage business, Mr. Gorman said. The bank did not disclose losses right away because they were not deemed material in the context of its overall results, he added.

The Archegos saga is likely to have regulatory repercussions, however, with a slew of U.S. watchdogs as well as the Senate banking committee all probing the incident to better understand why some banks were so exposed to a single client.

Mr. Gorman appeared exasperated at times during the call as he faced repeated questions from analysts about Archegos, distracting from the bank’s otherwise stellar performance.

Morgan Stanley’s shares were down 0.5 per cent in early trading.

“It’s not a financial event in the grand scheme of things, but it will likely raise concerns,” Oppenheimer analyst Chris Kotowski wrote in a note to clients.

Although Morgan Stanley’s Archegos loss dominated the discussion on Friday, its first-quarter profit comfortably beat expectations. Its report wrapped up a robust quarter for the biggest U.S. banks, which benefited from reserve releases and record capital markets activity.

A spike in trading, partly driven by a Reddit-fuelled trading frenzy in “meme” stocks like GameStop Corp., drove a 66-per-cent jump in revenue at Morgan Stanley’s institutional securities business.

Unlike rivals JPMorgan Chase & Co. and Bank of America , Morgan Stanley and Goldman Sachs lack big consumer lending units, which has limited their exposure to loan problems during the pandemic and allowed them to focus on investment banking and trading.

Morgan Stanley’s profit rose to US$3.98-billion, or US$2.19 per share, in the quarter ended March 31, from US$1.59-billion, or US$1.01 per share, a year ago.

Analysts were looking for a profit of US$1.70 per share, according to IBES data from Refinitiv.

Net revenue jumped 61 per cent to US15.72-billion.

Like bigger rival Goldman Sachs, Morgan Stanley benefited from an unprecedented boom in deal-making through special purpose acquisition companies (SPACs).

Global investment banking fees hit an all-time record of US$39.4-billion during the March quarter, according to data from Refinitiv.

Morgan Stanley also generated handsome fees from a spate of mergers and by underwriting numerous high-profile IPOs of companies including Affirm Holdings and AppLovin Corp. .

Its investment banking revenue more than doubled to US$2.6-billion.

Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.

Report an editorial error

Report a technical issue

Tickers mentioned in this story

Study and track financial data on any traded entity: click to open the full quote page. Data updated as of 15/11/24 0:39pm EST.

SymbolName% changeLast
MS-N
Morgan Stanley
+1.23%134.06
GS-N
Goldman Sachs Group
+0.84%593.54
NMR-N
Nomura Holdings Inc ADR
-0.68%5.86
DBMBF
Deutsche Bank
+7.81%1.725
DB-N
Deutsche Bank Ag
+1.49%16.98
WFC-C-N
Wells Fargo & Co.
-0.1%19.63
WFC-N
Wells Fargo & Company
+2.12%74.34
TRI-PR-B-T
Thomson Reuters Corp Prf Srs 2
0%13.67
TRI-T
Thomson Reuters Corp
-1.59%227.74
JPM-C-N
Jpmorgan Chase & Co. [Jpm/Pc]
-0.08%25.35
JPM-K-N
Jpmorgan Chase & Co. [Jpm/Pl]
-0.19%21.07
BAC-O-N
Bank of America Corp
-0.15%19.62
BAC-N
Bank of America Corp
+1.85%46.75
AFRM-Q
Affirm Holdings Inc Cl A
+5.53%56.15
APP-Q
Applovin Corp Cl A
+2.32%291.09

Follow related authors and topics

Authors and topics you follow will be added to your personal news feed in Following.

Interact with The Globe